In 2010, GMFB expression in serous ovarian carcinoma was found to be significantly enhanced than that in normal epithelium, benign serous adenoma, and borderline serous adenoma tissues and was associated with poor disease-free survival and overall survival [28]. This evidence concerns the gene GMFB and ovarian serous carcinoma.